Skye Bioscience, Inc. (SKYE)
0.649
-0.01
(-0.95%)
USD |
NASDAQ |
Mar 20, 16:00
0.6363
-0.01
(-1.96%)
After-Hours: 20:00
Skye Bioscience Research and Development Expense (Quarterly) : 11.29M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 31.90M |
| Merck & Co., Inc. | 2.499B |
| SIGA Technologies, Inc. | 5.041M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |